Author:
Wynn Julia,Martinez Josue,Duong Jimmy,Chiuzan Codruta,Phelan Jo C.,Fyer Abby,Klitzman Robert L.,Appelbaum Paul S.,Chung Wendy K.
Funder
National Human Genome Research Institute (US)
National Human Genome Research Institute
Reference32 articles.
1. Allain, D. C., Friedman, S., & Senter, L. (2012). Consumer awareness and attitudes about insurance discrimination post enactment of the genetic information nondiscrimination act. Familial Cancer, 11(4), 637–644.
2. Appelbaum, P. S., Waldman, C. R., Fyer, A., Klitzman, R., Parens, E., Martinez, J., et al. (2014). Informed consent for return of incidental findings in genomic research. Genetics in Medicine, 16(5), 367–373.
3. Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., & Weber, B. (2000). Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention, 9(11), 1251–1254.
4. Armstrong, K., Putt, M., Halbert, C. H., Grande, D., Schwartz, J. S., Liao, K., et al. (2012). The influence of health care policies and health care system distrust on willingness to undergo genetic testing. Medical Care, 50(5), 381–387.
5. Bennette, C. S., Trinidad, S. B., Fullerton, S. M., Patrick, D., Amendola, L., Burke, W., et al. (2013). Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT). Genetics in Medicine, 15(11), 873–881.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献